LASIK advancement: Alcon gets FDA approval for LADARVision system

Hunenberg, Switzerland-The FDA has approved Alcon Inc.'s LADARVision System for customized wavefront-guided laser eye surgery in the treatment of myopia.

Related Content:

Pharmacy

Comparable conscious sedation methods address individual patient needs

Investigators uncover health care disparities among US patients

Investigators zoom in on future of dry eye treatment